Clinical Trial Update: Descartes-08 Consolidation Treatment in Patients With High-Risk Multiple Myeloma High-Risk Multiple Myeloma Who Have Residual Disease After Induction Therapy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Descartes-08 consolidation therapy in high-risk multiple myeloma patients with residual disease after induction; the study was terminat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Descartes-08 Consolidation Therapy

Snippet

Sponsor: Cartesian Therapeutics | Conditions: Myeloma Multiple | Phase 2 | Status: TERMINATED | Results posted: 2024-10-08